Managed Care
Disease
Management

Cangrelor Versus Clopidogrel in Intraprocedural Stent Thrombosis (IPST): CHAMPION PHOENIX

Philippe Genereux, MD, of the Angiographic Core Laboratory, Cardiovascular Research Foundation in New York, NY, says that cangrelor was associated with significant reductions in the key endpoints of stent thrombosis and IPST when compared with clopidogrel.

Meetings

HealthIMPACT Southeast Tampa, FL January 23, 2015